Home  >  Products  >  DDAH2 (dimethylarginine dimethylaminohydrolase 2) Blocking Peptide (the N terminal of protein) (100ug)
DDAH2 (dimethylarginine dimethylaminohydrolase 2) Blocking Peptide (the N terminal of protein) (100ug)

DDAH2 (dimethylarginine dimethylaminohydrolase 2) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DDAH2 antibody (Catalogue #: ARP58611_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP58611
Size: 100 ug
Weight: 31kDa
Gene: 23564
Format: Lyophilized powder
Target: DDAH2 hydrolyzes N(G),N(G)-dimethyl-L-arginine (ADMA) and N(G)-monomethyl-L-arginine (MMA) which act as inhibitors of NOS. DDAH2 has therefore a role in nitric oxide generation.This gene belongs to the dimethylarginine dimethylaminohydrolase (DDAH) gene family. The encoded enzyme plays a role in nitric oxide generation by regulating cellular concentrations of methylarginines, which in turn inhibit nitric oxide synthase activity. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: DDAH; DDAHII; G6a; NG30
See Full Product Listings >